SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals is drawing heavy attention after Trump announced a US-Denmark-Greenland agreement granting the US permanent security access to Greenland and barring adversary investments, which traders view as a strategic tailwind for the company's Tanbreez rare earth project there. Sentiment is overwhelmingly bullish, with heavy short-squeeze speculation given elevated short interest, though skeptics argue the pactnot yet formally signeddoesn't change Tanbreez's funding or production timeline.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Conversation centers on Meta's Muse AI agent, with traders celebrating its climb to the top of app store charts and sharing early experiences using it for tasks like travel booking and email management, viewing the launch as evidence Meta can monetize AI ahead of the Meta Connect conference. Skeptics counter that Muse generates no revenue yet, citing sluggish performance and reports that Amazon blocked the agent's agentic shopping, leaving sentiment divided despite the buzz.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUI is seeing renewed attention as a sharp rally pushes the token back toward the closely watched one-dollar level, reigniting a bull-versus-bear debate. Bulls cite ETF accumulation, staking, and supply-squeeze tokenomics as fuel for further upside, while bears dismiss the move and point to past network outages and the protocol's asset-freezing capabilities as unresolved red flags.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is drawing attention as the token rallies off long-standing lows toward key resistance on elevated volume, a move many traders link to the leadership change that installed William Herkelrath as CEO in place of Staci Warden. Bulls view the new leadership alongside post-quantum mainnet upgrades as a potential turning point, while bears counter that foundation token sales and dilution will keep capping any recovery.

Lam Research Corp. engages in the design, manufacture, marketing, refurbishment, and provision of semiconductor processing equipment used in the fabrication of integrated circuits. It operates through the following geographical segments: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. The company was founded by David K. Lam in 1980 and is headquartered in Fremont, CA.

Lam Research Corp.

Lam Research is rebounding with the broader semiconductor equipment group as traders cite Lam's India chip-expansion plans and memory-capex catalysts  including SK Hynix subsidiary Solidigm exploring a first U.S. NAND fab and speculation that China's CXMT is entering NAND  after a steep slide tied to AI-slowdown fears. Bulls see the bottom in place, while skeptics dismiss the bounce as "generational bait."

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending after its investor day produced a cluster of announcements  a raised full-year 2026 revenue outlook incorporating the SkyWater acquisition, the unveiling of its sixth-generation Superion 256 quantum platform, and a commercial quantum-security agreement with Congruity360  which initially sparked a sharp rally before the stock gave back most of the gains. Community reaction is split, with bulls citing the guidance raise, manufacturing scale, and analyst support, while bears point to the sell-the-news fade, CEO share sales, and pressure from rising rates.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending on a cluster of open-market insider purchases, with CEO John Fieldly and multiple directors buying shares in quick succession. Bulls frame the repeated insider buys as a strong conviction signal and a potential bottom, while skeptics call the purchases too small to offset concerns over core-brand volume pressure and ongoing criticism of management.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is surging sharply after the launch of confidential perpetual futures powered by Hyperliquid, a privacy-first trading feature that traders are crediting for the explosive move. Community sentiment is largely bullish, with many framing the rally as part of a broader altcoin rotation and the privacy/AI narrative alongside Zcash, while skeptics argue the pump is whale-driven and lacks fundamental news.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

QCOM is trending after a steep sell-off on volume several times normal even as most semiconductor peers rallied, with traders unable to identify a clear company-specific trigger. The community is split between explanationsprofit-taking after the recent Amazon AI-chip deal run-up, algorithmic selling and options-expiry positioning, delayed reaction to a Zacks downgrade, and lingering handset/Apple-share and margin worrieswhile bulls are treating the flush as a dip-buy ahead of the Snapdragon Summit.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

A sharp AVAX rally is dominating the conversation, with traders attributing the move to reports that NYSE/ICE has been testing Avalanche's blockchain for a 24/7 tokenized securities platform, alongside a broader altcoin rotation and heavy short liquidations. Sentiment is split between bulls framing it as the start of an RWA/tokenization-driven altseason and skeptics calling it a pump that will reverse.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AbbVies agreement to acquire Apogee Therapeutics is the main catalyst, with traders viewing the deal as a way to strengthen its immunology and respiratory pipeline beyond the Humira decline. The community is broadly bullish on the strategic fit and healthcare-sector rotation, while some remain concerned about the acquisitions premium, debt burden, and delayed earnings contribution.

AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now?

Key PointsAbbVie's Qulipta could be racing toward another label expansion, given a recent clinical trial win...

AbbVie's Dividend Growth Remains Solid Despite a Moderate Yield

AbbVie's Dividend Growth Remains Solid Despite a Moderate Yield...

AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsAbbVie continues to diversify its revenue streams with successful expansions in immunology and aesthetics...

AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR (cariprazine) at Psych Congress 2026

AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR (cariprazine) at Psych Congress 2026 AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR (cariprazine) at Psych Congress 2026PR NewswireNORTH CHICAGO, Ill., Sept. 18, 2026 New data from...

AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) Meeting

AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) Meeting AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) MeetingPR...

Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications

Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss Medications Allergan Aesthetics Presents New Clinical Data Evaluating Skin Quality Improvements in Individuals Taking Medical Weight Loss MedicationsPR NewswireIRVINE...

How AbbVie's Neuroscience Portfolio Has Transformed Over the Years

ABBV's neuroscience portfolio has broadened across psychiatry, migraine and Parkinson's, driving strong growth and raising its 2026 outlook.

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health Campaign

AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health Campaign AbbVie Named Official Pharmaceutical Sponsor of the PGA TOUR and 2026 Presidents Cup, Launches Birdies for Brain Health CampaignPR NewswireNORTH CHICAGO, Ill., Sept. 15...

Allergan Aesthetics to Advance Scientific Dialogue on Skin Longevity, Aging Biology and Exosome Science at the 2026 Science of Skin Summit

Allergan Aesthetics to Advance Scientific Dialogue on Skin Longevity, Aging Biology and Exosome Science at the 2026 Science of Skin Summit Allergan Aesthetics to Advance Scientific Dialogue on Skin Longevity, Aging Biology and Exosome Science at the 2026 Science of Skin SummitPR NewswireIRVINE...

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

SLS Stock Heads For Worst Month In Over 2 Years — But Retail Bulls ‘Hold’ For AML Readout And Buyout Hopes

Equity

Bearish Sentiment

Track ABBV stock price, charts, news and real-time market activity on Stocktwits. Join the ABBV message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around AbbVie Inc stock.

ABBV Stock Price Today - Abbvie Inc News, Charts, Retail Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Microsoft Corp

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

SpaceX

Stocktwits Polls

Investors are closely tracking Phase 3 clinical readouts and performance data for key neuroscience and oncology drug assets.

Current Price	$263.96
Prev Close	$264.02
Open	$263.29
Dividend Yield	2.91%
50-Day Moving Average	$255.35
Beta	0.29
Avg. Volume	4.76M
PE Ratio	74.63

52-Week High	$267.47
52-Week Low	$190.75
Market Capitalization	$466.45B
EPS (Annual)	$2.36
Price to Book	-78.59
Revenue Per Employee	$1.07M

Feed

News

Sentiment

Earnings

NewFutures

Fundamentals

Info

ABBV Fundamentals